Skip to content

Tech
Consumer
Financial
Politics
- Trump
- US Budget
Health
Basic Materials
- Agriculture
- Metals & Mining
  - Cobalt
  - Zinc
  - Gold
  - Silver
  - Lithium
  - Uranium
  - Copper
Energy
- Oil & Gas
- Alternative Energy
  - Biofuels
  - Hydro
  - Solar
Industrials

Search

SEARCH FOR AN ARTICLE

Search

Tech
Consumer
Financial
Politics
- Trump
- US Budget
Health
Basic Materials
- Agriculture
- Metals & Mining
  - Cobalt
  - Zinc
  - Gold
  - Silver
  - Lithium
  - Uranium
  - Copper
Energy
- Oil & Gas
- Alternative Energy
  - Biofuels
  - Hydro
  - Solar
Industrials

HomeAcceleron Pharma stock

Acceleron Pharma stock

XLRN Stock Hits New High on Positive Trial Results of PAH Treatment

XLRN Stock Hits New High on Positive Trial Results of PAH Treatment

January 28, 2020

LATEST NEWS

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from StreetSignals.

I want e-mail alerts, updates, and offers and agree to the StreetSignals privacy policy.

Market Jar Media Inc. © 2024